In two large independent clinical trials (CORONA and GISSI-HF), baseline elevated PTX3 was associated with a higher risk of all-cause mortality cardiovascular mortality or hospitalization for worsening HF. This evidence concerns the gene PTX3 and hydrops fetalis.